PMID: 15229048Jul 2, 2004Paper

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain

The American Journal of Psychiatry
Nora D VolkowJames M Swanson

Abstract

Methylphenidate is the most commonly prescribed drug for attention deficit hyperactivity disorder (ADHD), yet its therapeutic mechanisms are poorly understood. The objective of this study was to assess if methylphenidate, by increasing dopamine (neurotransmitter involved in motivation) in brain, would enhance the saliency of an academic task, making it more interesting. Healthy subjects (N=16) underwent positron emission tomography with [(11)C]raclopride (dopamine D(2) receptor radioligand that competes with endogenous dopamine for binding) to assess the effects of oral methylphenidate (20 mg) on extracellular dopamine in the striatum. The authors compared the effects of methylphenidate during an academic task (solving mathematical problems with monetary reinforcement) and a neutral task (passively viewing cards with no remuneration). In parallel, the effects of methylphenidate on the interest that the academic task elicited were also evaluated. Methylphenidate, when coupled with the mathematical task, significantly increased extracellular dopamine, but this did not occur when coupled with the neutral task. The mathematical task did not increase dopamine when coupled with placebo. Subjective reports about interest and motivatio...Continue Reading

Citations

Sep 10, 2009·JAMA : the Journal of the American Medical Association·Nora D VolkowJames M Swanson
Feb 28, 2013·The Psychiatric Quarterly·Bianca D Patel, Drew H Barzman
Jul 19, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gail Tripp, Jeff Wickens
Jul 18, 2012·Development and Psychopathology·Walter MatthysDennis J L G Schutter
Aug 31, 2011·Experimental and Clinical Psychopharmacology·Alison Looby, Mitch Earleywine
Jun 17, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M Riverin, A Tremblay
Dec 14, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P A GrazianoG R Geffken
Feb 29, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Louk J M J VanderschurenAnton N M Schoffelmeer
Jun 27, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sarojini SenguptaRidha Joober
Oct 1, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·James SwansonNora D Volkow
Feb 10, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel K Campbell-MeiklejohnAndreas Roepstorff
Feb 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andre F MarquandMitul A Mehta
Apr 25, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marieke E van der SchaafRoshan Cools
Feb 19, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Leah M MayoMarkus Heilig
May 18, 2013·The International Journal of Clinical and Experimental Hypnosis·Salvador AmigóJoan C Micó
Oct 1, 2013·Journal of Addictive Diseases·Carlos RonceroMiguel Casas
Nov 3, 2005·Journal of Child and Adolescent Psychopharmacology·Emily MacDonald Fredericks, Scott H Kollins
Apr 1, 2005·Current Opinion in Pediatrics·Alison Schonwald
Jul 22, 2005·Journal of Integrative Neuroscience·Nicholas J CooperEvian Gordon
Sep 20, 2008·Journal of Psychopharmacology·R Z GoldsteinN D Volkow
Jun 26, 2010·Journal of Attention Disorders·Margaret A SheridanMark D'Esposito
Feb 6, 2013·PloS One·Zia ChoudhryRidha Joober
Jul 15, 2005·Pharmacogenomics·Guilherme PolanczykLuis Augusto Rohde
Jan 21, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nora D VolkowJames M Swanson
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Darko TuricEdmund Sonuga-Barke
Sep 12, 2006·Primary Care Companion to the Journal of Clinical Psychiatry
Feb 25, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Scott H Kollins, R Alison Adcock
Jan 8, 2014·European Child & Adolescent Psychiatry·A MorenoO Vilarroya
Jul 20, 2005·Expert Review of Neurotherapeutics·James J McGoughRobert Suddath
May 27, 2014·Expert Opinion on Drug Metabolism & Toxicology·Jan FrölichAnja Görtz-Dorten
Sep 28, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tai-Li ChouSusan Shur-Fen Gau
Feb 22, 2012·Medical Hypotheses·Elizabeth E Van VoorheesScott H Kollins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.